Drug Discovery & Development | FDA grants Teva's Treanda orphan drug status Globes ... that the US Food and Drug Administration (FDA) has granted orphan drug exclusivity for Treanda through October 2015 for the treatment of indolent B-cell non-Hodgkin lymphoma that has progressed during or within six months of treatment with ... Teva Pharmaceutical Industries Limited : Teva Announces Additional Regulatory ... Teva Pharma Reports Addl. Regulatory Exclusivity For TREANDA For Injection |
